1. Home
  2. HCWB vs DAIO Comparison

HCWB vs DAIO Comparison

Compare HCWB & DAIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HCWB
  • DAIO
  • Stock Information
  • Founded
  • HCWB 2018
  • DAIO 1969
  • Country
  • HCWB United States
  • DAIO United States
  • Employees
  • HCWB N/A
  • DAIO N/A
  • Industry
  • HCWB Biotechnology: Pharmaceutical Preparations
  • DAIO Electrical Products
  • Sector
  • HCWB Health Care
  • DAIO Industrials
  • Exchange
  • HCWB Nasdaq
  • DAIO Nasdaq
  • Market Cap
  • HCWB 17.2M
  • DAIO 26.9M
  • IPO Year
  • HCWB 2021
  • DAIO N/A
  • Fundamental
  • Price
  • HCWB $0.35
  • DAIO $2.40
  • Analyst Decision
  • HCWB
  • DAIO Strong Buy
  • Analyst Count
  • HCWB 0
  • DAIO 1
  • Target Price
  • HCWB N/A
  • DAIO $4.00
  • AVG Volume (30 Days)
  • HCWB 281.9K
  • DAIO 23.0K
  • Earning Date
  • HCWB 03-31-2025
  • DAIO 04-24-2025
  • Dividend Yield
  • HCWB N/A
  • DAIO N/A
  • EPS Growth
  • HCWB N/A
  • DAIO N/A
  • EPS
  • HCWB N/A
  • DAIO N/A
  • Revenue
  • HCWB $3,495,990.00
  • DAIO $21,769,000.00
  • Revenue This Year
  • HCWB $229.19
  • DAIO N/A
  • Revenue Next Year
  • HCWB N/A
  • DAIO $0.21
  • P/E Ratio
  • HCWB N/A
  • DAIO N/A
  • Revenue Growth
  • HCWB 22.27
  • DAIO N/A
  • 52 Week Low
  • HCWB $0.21
  • DAIO $2.29
  • 52 Week High
  • HCWB $2.52
  • DAIO $3.99
  • Technical
  • Relative Strength Index (RSI)
  • HCWB 46.07
  • DAIO 31.69
  • Support Level
  • HCWB $0.33
  • DAIO $2.50
  • Resistance Level
  • HCWB $0.38
  • DAIO $3.08
  • Average True Range (ATR)
  • HCWB 0.03
  • DAIO 0.14
  • MACD
  • HCWB -0.00
  • DAIO -0.06
  • Stochastic Oscillator
  • HCWB 33.18
  • DAIO 1.47

About HCWB HCW Biologics Inc.

HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company has developed TOBI discovery platform, or Tissue factor-based fusion discovery platform, for the design of category-defining immunotherapeutic drugs. It has selected two molecules as its product candidate; HCW9218 and HCW9302. HCW9218 is a bifunctional immunotherapeutic designed with the capabilities to neutralize transforming growth and stimulate immune cells. HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes.

About DAIO Data I/O Corporation

Data I/O Corp is a provider of programming, security deployment, security provisioning and associated Intellectual Property protection and management solutions used in electronics manufacturing with flash memory, microcontrollers, and flash memory-based intelligent devices as well as secure element devices, authentication devices and secure microcontrollers. It is engaged in focused on the design, manufacturing and sale of programming systems used by designers and manufacturers of electronic products. It has its geographic presence in United States, Europe and Rest of the world.

Share on Social Networks: